ArticleNuclear medicine and biology2013

Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors.

Majiong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.